Anna Eramo's most recent trade in LB Pharmaceuticals Inc was a trade of 155,812 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Sept. 10, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| LB Pharmaceuticals Inc | Anna Eramo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 155,812 | 155,812 | - | - | Employee Stock Option (Right to Buy) | |
| LB Pharmaceuticals Inc | Anna Eramo | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Sep 2025 | 26,893 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| LB Pharmaceuticals Inc | Anna Eramo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 26,893 | 26,893 | - | - | Employee Stock Option (Right to Buy) | |
| LB Pharmaceuticals Inc | Anna Eramo | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 10 Sep 2025 | 6,275 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| LB Pharmaceuticals Inc | Anna Eramo | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Sep 2025 | 6,275 | 6,275 | - | - | Employee Stock Option (Right to Buy) |